We are live on
!
Find out more
FLXN
Flexion Therapeutics, Inc.
FLXN
FLXN
Delisted
FLXN was delisted on the 18th of November, 2021.
145 hedge funds and large institutions have $421M invested in Flexion Therapeutics, Inc. in 2021 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 53 increasing their positions, 43 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
24% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 17
23% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 43
3% more funds holding
Funds holding: 141 → 145 (+4)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
27% less capital invested
Capital invested by funds: $580M → $421M (-$159M)
28% less call options, than puts
Call options by funds: $1.83M | Put options by funds: $2.55M
Holders
145
Holders Change
+4
Holders Change %
+2.84%
% of All Funds
2.55%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
21
Increased
53
Reduced
43
Closed
17
Calls
$1.83M
Puts
$2.55M
Net Calls
-$713K
Net Calls Change
+$1.08M
Top Buyers
| 1 |
CC
Clearline Capital
New York
|
+$16.1M |
| 2 |
Two Sigma Investments
New York
|
+$8.25M |
| 3 |
Two Sigma Advisers
New York
|
+$7.28M |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$5.99M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$4.91M |
